258 related articles for article (PubMed ID: 2846825)
21. Regulation of calcium current by low-Km cyclic AMP phosphodiesterases in cardiac cells.
Fischmeister R; Hartzell HC
Mol Pharmacol; 1990 Sep; 38(3):426-33. PubMed ID: 1698253
[TBL] [Abstract][Full Text] [Related]
22. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
Weishaar RE; Quade MM; Schenden JA; Evans DB
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170
[TBL] [Abstract][Full Text] [Related]
23. Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism.
Ahn HS; Eardley D; Watkins R; Prioli N
Biochem Pharmacol; 1986 Apr; 35(7):1113-21. PubMed ID: 2421728
[TBL] [Abstract][Full Text] [Related]
24. Concanavalin A stimulates the Rolipram-sensitive isoforms of cyclic nucleotide phosphodiesterase in rat thymic lymphocytes.
Valette L; Prigent AF; Némoz G; Anker G; Macovschi O; Lagarde M
Biochem Biophys Res Commun; 1990 Jun; 169(3):864-72. PubMed ID: 2163636
[TBL] [Abstract][Full Text] [Related]
25. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
Rose RJ; Liu H; Palmer D; Maurice DH
Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930
[TBL] [Abstract][Full Text] [Related]
26. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
Barnette MS; Manning CD; Price WJ; Barone FC
J Pharmacol Exp Ther; 1993 Feb; 264(2):801-12. PubMed ID: 7679736
[TBL] [Abstract][Full Text] [Related]
27. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages.
Turner NC; Wood LJ; Burns FM; Gueremy T; Souness JE
Br J Pharmacol; 1993 Apr; 108(4):876-83. PubMed ID: 8387385
[TBL] [Abstract][Full Text] [Related]
28. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
Elks ML; Manganiello VC
Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
[TBL] [Abstract][Full Text] [Related]
29. Phosphodiesterase isozyme inhibition, activation of the cAMP system, and positive inotropy mediated by milrinone in isolated guinea pig cardiac muscle.
Silver PJ; Harris AL; Canniff PC; Lepore RE; Bentley RG; Hamel LT; Evans DB
J Cardiovasc Pharmacol; 1989 Apr; 13(4):530-40. PubMed ID: 2470989
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary effects of type V cyclic GMP specific phosphodiesterase inhibition in the anaesthetized guinea-pig.
Turner NC; Dolan JS; Grimsditch D; Lamb J; Worby A; Murray KJ; Coates WJ; Warrington BH
Br J Pharmacol; 1994 Apr; 111(4):1198-204. PubMed ID: 8032606
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
[TBL] [Abstract][Full Text] [Related]
32. The ability of phosphodiesterase IV inhibitors to suppress superoxide production in guinea pig eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activity.
Barnette MS; Manning CD; Cieslinski LB; Burman M; Christensen SB; Torphy TJ
J Pharmacol Exp Ther; 1995 May; 273(2):674-9. PubMed ID: 7752069
[TBL] [Abstract][Full Text] [Related]
33. High activity of low-Michaelis-Menten constant 3', 5'-cyclic adenosine monophosphate-phosphodiesterase isozymes in renal inner medulla of mice with hereditary nephrogenic diabetes insipidus.
Takeda S; Lin CT; Morgano PG; McIntyre SJ; Dousa TP
Endocrinology; 1991 Jul; 129(1):287-94. PubMed ID: 1647298
[TBL] [Abstract][Full Text] [Related]
34. Myofibrillar bound cyclic nucleotide phosphodiesterase in heart and skeletal muscle.
Worby A; Mensah LM; Murray KJ
Biochem Soc Trans; 1992 May; 20(2):129S. PubMed ID: 1327896
[No Abstract] [Full Text] [Related]
35. Characterization of cyclic AMP phosphodiesterase isozymes in rat parotid gland.
Imai A; Nashida T; Shimomura H
Arch Oral Biol; 1995 Feb; 40(2):165-8. PubMed ID: 7794130
[TBL] [Abstract][Full Text] [Related]
36. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
Maurice DH
Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
[TBL] [Abstract][Full Text] [Related]
37. Cellular distribution of phosphodiesterase isoforms in rat cardiac tissue.
Bode DC; Kanter JR; Brunton LL
Circ Res; 1991 Apr; 68(4):1070-9. PubMed ID: 1849058
[TBL] [Abstract][Full Text] [Related]
38. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta.
Lugnier C; Schoeffter P; Le Bec A; Strouthou E; Stoclet JC
Biochem Pharmacol; 1986 May; 35(10):1743-51. PubMed ID: 2423089
[TBL] [Abstract][Full Text] [Related]
39. Delayed stimulation of bone resorption in vitro by phosphodiesterase inhibitors requires the presence of adenylate cyclase stimulation.
Ransjö M; Fredholm BB; Lerner UH
Bone Miner; 1988 Jan; 3(3):225-34. PubMed ID: 2462948
[TBL] [Abstract][Full Text] [Related]
40. Examination of relative rates of cAMP synthesis and degradation in crude membranes of adipocytes treated with hormones.
Gettys TW; Okonogi K; Tarry WC; Johnston J; Horton C; Taylor IL
Second Messengers Phosphoproteins; 1990; 13(1):37-49. PubMed ID: 1962820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
